Synthesis Segment News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Synthesis Segment. Real-time updates on events, politics, business and more.

Oncology Dominates Active Pharmaceutical Ingredient CDMO Market with 35.5% Revenue Share in 2022, Fueled by Growing Demand for Potent APIs

November 11, 2023

/PRNewswire/ -- The "Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report By Product (Highly Potent API, Antibody Drug Conjugate),...

United States Cros Cmos Cdmos Laura Wood Asia Pacific Samsung Biologics Piramal Pharma Solutions

Source: prnewswire.com

Global Active Pharmaceutical Ingredient CDMO Market to

November 10, 2023

Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The

United States Cros Cmos Cdmos Samsung Biologics Asia Pacific Catalent Inc Cordenpharma International

Source: globenewswire.com

High Potency API Contract Manufacturing Global Market to Reach $14.65 Billion by 2030 at a CAGR of 9%

October 20, 2022

/PRNewswire/ -- The "High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product Type (Innovative, Generic), by Dosage Form...

Apis Hpapis Laura Wood Cordenpharma International Vxp Pharma Inc Office Hours Call Aurigene Pharmaceutical Services Ltd

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Synthesis Segment News Today

Oncology Dominates Active Pharmaceutical Ingredient CDMO Market with 35.5% Revenue Share in 2022, Fueled by Growing Demand for Potent APIs

Global Active Pharmaceutical Ingredient CDMO Market to

High Potency API Contract Manufacturing Global Market to Reach $14.65 Billion by 2030 at a CAGR of 9%

Explore More Categories